Altimmune

Altimmune Diluted EPS

The Diluted Earnings per Share of Altimmune (ALT) as of Nov 19, 2026 is -0.88 USD. In the previous year, Diluted Earnings per Share was -1.33 USD — a change of -34.36% (higher).

Diluted EPS

-0.88USD

YoY

-34.36%

Last updated:

Diluted Earnings per Share of Altimmune is 2025 -0.88 USD. Diluted Earnings per Share of Altimmune was 2024 -1.33 USD. It decreases by -34.36% higher compared to the previous year.

The Altimmune Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-4.13 USD
Jan 1, 2019
-1.36 USD
Jan 1, 2020
-1.26 USD
Jan 1, 2021
-2.33 USD
Jan 1, 2022
-1.69 USD
Jan 1, 2023
-1.51 USD
Jan 1, 2024
-1.33 USD
Jan 1, 2025
-0.88 USD
The Altimmune Diluted EPS history
YEARDiluted EPSYoY
-0.88USD-34.36%
-1.33USD-11.86%
-1.51USD-10.63%
-1.69USD-27.26%
-2.33USD+84.72%
-1.26USD-7.19%
-1.36USD-67.10%
-4.13USD-94.03%
-69.14USD-108.17%
846.16USD-5,380.01%
-16.03USD-65.66%
-46.67USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

Diluted Earnings per Share of Altimmune is -0.88 USD in 2025.

Diluted Earnings per Share of Altimmune changed from -1.33 USD to -0.88 USD, representing a -34.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Altimmune since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Altimmune

All Key Metrics — Altimmune